Global Siponimod Market Growth 2022-2028
- LP 4890948
- 73 Pages
- March 2022
- Pharmaceuticals
The United States Siponimod market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Siponimod market, reaching US$ million by the year 2028. As for the Europe Siponimod landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Siponimod players cover Novartis, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Siponimod market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
0.25mg
0.2mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Retail Pharmacy
Hospital Pharmacy
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novartis
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Siponimod Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Siponimod by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Siponimod by Country/Region, 2017, 2022 & 2028
2.2 Siponimod Segment by Type
2.2.1 0.25mg
2.2.2 0.2mg
2.3 Siponimod Sales by Type
2.3.1 Global Siponimod Sales Market Share by Type (2017-2022)
2.3.2 Global Siponimod Revenue and Market Share by Type (2017-2022)
2.3.3 Global Siponimod Sale Price by Type (2017-2022)
2.4 Siponimod Segment by Application
2.4.1 Retail Pharmacy
2.4.2 Hospital Pharmacy
2.4.3 Other
2.5 Siponimod Sales by Application
2.5.1 Global Siponimod Sale Market Share by Application (2017-2022)
2.5.2 Global Siponimod Revenue and Market Share by Application (2017-2022)
2.5.3 Global Siponimod Sale Price by Application (2017-2022)
3 Global Siponimod by Company
3.1 Global Siponimod Breakdown Data by Company
3.1.1 Global Siponimod Annual Sales by Company (2020-2022)
3.1.2 Global Siponimod Sales Market Share by Company (2020-2022)
3.2 Global Siponimod Annual Revenue by Company (2020-2022)
3.2.1 Global Siponimod Revenue by Company (2020-2022)
3.2.2 Global Siponimod Revenue Market Share by Company (2020-2022)
3.3 Global Siponimod Sale Price by Company
3.4 Key Manufacturers Siponimod Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Siponimod Product Location Distribution
3.4.2 Players Siponimod Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Siponimod by Geographic Region
4.1 World Historic Siponimod Market Size by Geographic Region (2017-2022)
4.1.1 Global Siponimod Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Siponimod Annual Revenue by Geographic Region
4.2 World Historic Siponimod Market Size by Country/Region (2017-2022)
4.2.1 Global Siponimod Annual Sales by Country/Region (2017-2022)
4.2.2 Global Siponimod Annual Revenue by Country/Region
4.3 Americas Siponimod Sales Growth
4.4 APAC Siponimod Sales Growth
4.5 Europe Siponimod Sales Growth
4.6 Middle East & Africa Siponimod Sales Growth
5 Americas
5.1 Americas Siponimod Sales by Country
5.1.1 Americas Siponimod Sales by Country (2017-2022)
5.1.2 Americas Siponimod Revenue by Country (2017-2022)
5.2 Americas Siponimod Sales by Type
5.3 Americas Siponimod Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Siponimod Sales by Region
6.1.1 APAC Siponimod Sales by Region (2017-2022)
6.1.2 APAC Siponimod Revenue by Region (2017-2022)
6.2 APAC Siponimod Sales by Type
6.3 APAC Siponimod Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Siponimod by Country
7.1.1 Europe Siponimod Sales by Country (2017-2022)
7.1.2 Europe Siponimod Revenue by Country (2017-2022)
7.2 Europe Siponimod Sales by Type
7.3 Europe Siponimod Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Siponimod by Country
8.1.1 Middle East & Africa Siponimod Sales by Country (2017-2022)
8.1.2 Middle East & Africa Siponimod Revenue by Country (2017-2022)
8.2 Middle East & Africa Siponimod Sales by Type
8.3 Middle East & Africa Siponimod Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Siponimod
10.3 Manufacturing Process Analysis of Siponimod
10.4 Industry Chain Structure of Siponimod
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Siponimod Distributors
11.3 Siponimod Customer
12 World Forecast Review for Siponimod by Geographic Region
12.1 Global Siponimod Market Size Forecast by Region
12.1.1 Global Siponimod Forecast by Region (2023-2028)
12.1.2 Global Siponimod Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Siponimod Forecast by Type
12.7 Global Siponimod Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Siponimod Product Offered
13.1.3 Novartis Siponimod Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
14 Research Findings and Conclusion
Table 1. Siponimod Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Siponimod Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.25mg
Table 4. Major Players of 0.2mg
Table 5. Global Siponimod Sales by Type (2017-2022) & (K Units)
Table 6. Global Siponimod Sales Market Share by Type (2017-2022)
Table 7. Global Siponimod Revenue by Type (2017-2022) & ($ million)
Table 8. Global Siponimod Revenue Market Share by Type (2017-2022)
Table 9. Global Siponimod Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Siponimod Sales by Application (2017-2022) & (K Units)
Table 11. Global Siponimod Sales Market Share by Application (2017-2022)
Table 12. Global Siponimod Revenue by Application (2017-2022)
Table 13. Global Siponimod Revenue Market Share by Application (2017-2022)
Table 14. Global Siponimod Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Siponimod Sales by Company (2020-2022) & (K Units)
Table 16. Global Siponimod Sales Market Share by Company (2020-2022)
Table 17. Global Siponimod Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Siponimod Revenue Market Share by Company (2020-2022)
Table 19. Global Siponimod Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Siponimod Producing Area Distribution and Sales Area
Table 21. Players Siponimod Products Offered
Table 22. Siponimod Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Siponimod Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Siponimod Sales Market Share Geographic Region (2017-2022)
Table 27. Global Siponimod Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Siponimod Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Siponimod Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Siponimod Sales Market Share by Country/Region (2017-2022)
Table 31. Global Siponimod Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Siponimod Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Siponimod Sales by Country (2017-2022) & (K Units)
Table 34. Americas Siponimod Sales Market Share by Country (2017-2022)
Table 35. Americas Siponimod Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Siponimod Revenue Market Share by Country (2017-2022)
Table 37. Americas Siponimod Sales by Type (2017-2022) & (K Units)
Table 38. Americas Siponimod Sales Market Share by Type (2017-2022)
Table 39. Americas Siponimod Sales by Application (2017-2022) & (K Units)
Table 40. Americas Siponimod Sales Market Share by Application (2017-2022)
Table 41. APAC Siponimod Sales by Region (2017-2022) & (K Units)
Table 42. APAC Siponimod Sales Market Share by Region (2017-2022)
Table 43. APAC Siponimod Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Siponimod Revenue Market Share by Region (2017-2022)
Table 45. APAC Siponimod Sales by Type (2017-2022) & (K Units)
Table 46. APAC Siponimod Sales Market Share by Type (2017-2022)
Table 47. APAC Siponimod Sales by Application (2017-2022) & (K Units)
Table 48. APAC Siponimod Sales Market Share by Application (2017-2022)
Table 49. Europe Siponimod Sales by Country (2017-2022) & (K Units)
Table 50. Europe Siponimod Sales Market Share by Country (2017-2022)
Table 51. Europe Siponimod Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Siponimod Revenue Market Share by Country (2017-2022)
Table 53. Europe Siponimod Sales by Type (2017-2022) & (K Units)
Table 54. Europe Siponimod Sales Market Share by Type (2017-2022)
Table 55. Europe Siponimod Sales by Application (2017-2022) & (K Units)
Table 56. Europe Siponimod Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Siponimod Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Siponimod Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Siponimod Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Siponimod Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Siponimod Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Siponimod Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Siponimod Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Siponimod Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Siponimod
Table 66. Key Market Challenges & Risks of Siponimod
Table 67. Key Industry Trends of Siponimod
Table 68. Siponimod Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Siponimod Distributors List
Table 71. Siponimod Customer List
Table 72. Global Siponimod Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Siponimod Sales Market Forecast by Region
Table 74. Global Siponimod Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Siponimod Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Siponimod Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Siponimod Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Siponimod Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Siponimod Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Siponimod Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Siponimod Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Siponimod Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Siponimod Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Siponimod Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Siponimod Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Siponimod Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Siponimod Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Siponimod Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Siponimod Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Siponimod Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Siponimod Revenue Market Share Forecast by Application (2023-2028)
Table 92. Novartis Basic Information, Siponimod Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis Siponimod Product Offered
Table 94. Novartis Siponimod Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Novartis Main Business
Table 96. Novartis Latest Developments
List of Figures
Figure 1. Picture of Siponimod
Figure 2. Siponimod Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Siponimod Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Siponimod Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Siponimod Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.25mg
Figure 10. Product Picture of 0.2mg
Figure 11. Global Siponimod Sales Market Share by Type in 2021
Figure 12. Global Siponimod Revenue Market Share by Type (2017-2022)
Figure 13. Siponimod Consumed in Retail Pharmacy
Figure 14. Global Siponimod Market: Retail Pharmacy (2017-2022) & (K Units)
Figure 15. Siponimod Consumed in Hospital Pharmacy
Figure 16. Global Siponimod Market: Hospital Pharmacy (2017-2022) & (K Units)
Figure 17. Siponimod Consumed in Other
Figure 18. Global Siponimod Market: Other (2017-2022) & (K Units)
Figure 19. Global Siponimod Sales Market Share by Application (2017-2022)
Figure 20. Global Siponimod Revenue Market Share by Application in 2021
Figure 21. Siponimod Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Siponimod Revenue Market Share by Company in 2021
Figure 23. Global Siponimod Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Siponimod Revenue Market Share by Geographic Region in 2021
Figure 25. Global Siponimod Sales Market Share by Region (2017-2022)
Figure 26. Global Siponimod Revenue Market Share by Country/Region in 2021
Figure 27. Americas Siponimod Sales 2017-2022 (K Units)
Figure 28. Americas Siponimod Revenue 2017-2022 ($ Millions)
Figure 29. APAC Siponimod Sales 2017-2022 (K Units)
Figure 30. APAC Siponimod Revenue 2017-2022 ($ Millions)
Figure 31. Europe Siponimod Sales 2017-2022 (K Units)
Figure 32. Europe Siponimod Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Siponimod Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Siponimod Revenue 2017-2022 ($ Millions)
Figure 35. Americas Siponimod Sales Market Share by Country in 2021
Figure 36. Americas Siponimod Revenue Market Share by Country in 2021
Figure 37. United States Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Siponimod Sales Market Share by Region in 2021
Figure 42. APAC Siponimod Revenue Market Share by Regions in 2021
Figure 43. China Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Siponimod Sales Market Share by Country in 2021
Figure 50. Europe Siponimod Revenue Market Share by Country in 2021
Figure 51. Germany Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Siponimod Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Siponimod Revenue Market Share by Country in 2021
Figure 58. Egypt Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Siponimod Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Siponimod in 2021
Figure 64. Manufacturing Process Analysis of Siponimod
Figure 65. Industry Chain Structure of Siponimod
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
